Kang et al., 2013 and Jia et al., 2016 showed that inhibition of Notch-1/NK-κB pathway via a small molecular compound Rhamnetin leaded to a decreased radioresistance or multi-drug resistance of human cancers [23, 40]. Here, NOTCH1 is linked to cancer.